Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

William Pridgen Biography and Net Worth

Director of Virios Therapeutics

William L. Pridgen, M.D. is our founder and has been a director since 2018. Dr. Pridgen is a board-certified surgeon practicing with Tuscaloosa Surgical Associates, P.C. in Tuscaloosa, Alabama. Dr. Pridgen obtained his B.S. in Biology from Rhodes College, attending the medical school and completing his surgical residency at the University of Tennessee College of Medicine. Dr. Pridgen is certified in general surgery and is a fellow of the American College of Surgeons. Dr. Pridgen has spent nearly 20 years searching for effective treatments in IBS, FM, and MECFS, and served as a physician and surgeon in the United States Navy for five years.

What is William Pridgen's net worth?: The estimated net worth of William Pridgen is at least $135,317.00 as of August 21st, 2023. Dr. Pridgen owns 52,045 shares of Virios Therapeutics stock worth more than $135,317 as of November 21st. This net worth evaluation does not reflect any other investments that Dr. Pridgen may own. Additionally, Dr. Pridgen receives a salary of $35,000.00 as Director at Virios Therapeutics. Learn More about William Pridgen's net worth.
How old is William Pridgen?: Dr. Pridgen is currently 63 years old. There are 4 older executives and no younger executives at Virios Therapeutics. The oldest executive at Virios Therapeutics is Dr. R. Michael Gendreau M.D., Ph.D., Chief Medical Officer, who is 68 years old. Learn More on William Pridgen's age.
What is William Pridgen's salary?: As the Director of Virios Therapeutics, Inc., Dr. Pridgen earns $35,000.00 per year. There are 4 executives that earn more than Dr. Pridgen. The highest earning executive at Virios Therapeutics is Mr. Gregory Duncan, Chairman & CEO, who commands a salary of $566,920.00 per year. Learn More on William Pridgen's salary.
How do I contact William Pridgen?: The corporate mailing address for Dr. Pridgen and other Virios Therapeutics executives is , , . Virios Therapeutics can also be reached via phone at 866-620-8655 and via email at [email protected]. Learn More on William Pridgen's contact information.
Has William Pridgen been buying or selling shares of Virios Therapeutics?: William Pridgen has not been actively trading shares of Virios Therapeutics during the past quarter. Most recently, on Monday, August 21st, William Pridgen bought 15,335 shares of Virios Therapeutics stock. The stock was acquired at an average cost of $1.30 per share, with a total value of $19,935.50. Following the completion of the transaction, the director now directly owns 52,045 shares of the company's stock, valued at $67,658.50. Learn More on William Pridgen's trading history.
Who are Virios Therapeutics' active insiders?: Virios Therapeutics' insider roster includes Gregory Duncan (CEO), William Pridgen (Director), and Richard Whitley (Director). Learn More on Virios Therapeutics' active insiders.

William Pridgen Insider Trading History at Virios Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2023	Buy	15,335	$1.30	$19,935.50	52,045
5/17/2022	Buy	13,450	$4.38	$58,911.00	36,469
3/29/2022	Buy	600	$4.94	$2,964.00
3/23/2022	Buy	2,197	$5.46	$11,995.62
1/27/2022	Buy	4,180	$5.98	$24,996.40
12/21/2021	Buy	8,827	$5.66	$49,960.82
7/7/2021	Buy	942	$6.32	$5,953.44
1/29/2021	Buy	3,500	$7.47	$26,145.00	727,993
12/17/2020	Buy	1,500	$11.98	$17,970.00	727,192

William Pridgen Buying and Selling Activity at Virios Therapeutics

Virios Therapeutics Company Overview

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Today's Range

Now: $2.60

$1.76

$3.03

50 Day Range

MA: $2.48

$0.14

$4.99

2 Week Range

Now: $2.60

$0.13

$1.04

Volume

637,000 shs

Average Volume

1,049,645 shs

Market Capitalization

$50.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide

William Pridgen Biography and Net Worth

What is William Pridgen's net worth?

How old is William Pridgen?

What is William Pridgen's salary?

How do I contact William Pridgen?

Has William Pridgen been buying or selling shares of Virios Therapeutics?

Who are Virios Therapeutics' active insiders?